Literature DB >> 30276728

Refractory chylous pleural effusion with systemic lupus erythematosus : Surgical treatment when steroid/immunosuppressant resistant.

Peng Song1, JingCheng Zhang2, CongCong Shang3, Li Zhang4.   

Abstract

We analyzed four cases of systemic lupus erythematosus (SLE) with chylous pleural effusion treated in our hospital from June 2013 to May 2017. The three females and one male ranged in age from 22 to 33 years. The length of disease course was 20 to 120 months. Treatment with glucocorticoids and immunosuppressants (cyclophosphamide or cyclosporine A) did not reduce chylous pleural effusion. Lymphatic obstruction was found in all patients after direct lymphangiography and the pleural effusion was significantly reduced after surgery. A literature search identified six previously reported patients with SLE and chylous pleural effusion. Five were sensitive to classic immunosuppression treatment, probably due to early intervention. However, as shown here, the thoracic duct can be involved in SLE, leading to an intractable chylous pleural effusion with no response to medical treatment. Surgery would be a better choice when lymphatic mechanical obstruction is found.

Entities:  

Keywords:  Chylous pleural effusion; Immunosuppressants; Resistant; Steroids; Thoracic duct

Mesh:

Substances:

Year:  2019        PMID: 30276728     DOI: 10.1007/s00393-018-0545-z

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  12 in total

1.  Chylothorax as the initial presentation of systemic lupus erythematosus: a case report.

Authors:  Yeong-Jang Lin; Der-Yuan Chen; Joung-Liang Lan; Tsu-Yi Hsieh
Journal:  Clin Rheumatol       Date:  2006-08-22       Impact factor: 2.980

Review 2.  Systemic lupus erythematosus.

Authors:  Anisur Rahman; David A Isenberg
Journal:  N Engl J Med       Date:  2008-02-28       Impact factor: 91.245

Review 3.  Atraumatic chylous ascites: systematic review on symptoms and causes.

Authors:  Daniel C Steinemann; Daniel Dindo; Pierre-Alain Clavien; Antonio Nocito
Journal:  J Am Coll Surg       Date:  2011-03-12       Impact factor: 6.113

4.  Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus.

Authors:  M C Hochberg
Journal:  Arthritis Rheum       Date:  1997-09

5.  Etiology of chylothorax in 203 patients.

Authors:  Clinton H Doerr; Mark S Allen; Francis C Nichols; Jay H Ryu
Journal:  Mayo Clin Proc       Date:  2005-07       Impact factor: 7.616

6.  Successful treatment of recurrent pleural and pericardial effusions with tocilizumab in a patient with systemic lupus erythematous.

Authors:  Vanessa Ocampo; Derek Haaland; K Legault; Shika Mittoo; Emily Aitken
Journal:  BMJ Case Rep       Date:  2016-08-08

Review 7.  Chylothorax: diagnosis and management in children.

Authors:  Manuel Soto-Martinez; John Massie
Journal:  Paediatr Respir Rev       Date:  2009-09-26       Impact factor: 2.726

8.  Chylous ascites and chylothorax as presentation of a systemic progression of discoid lupus.

Authors:  Diego Jorge Manzella; Pablo Nicolás Dettori; Mariano Luis Hertimian; Marcelo José Melero
Journal:  J Clin Rheumatol       Date:  2013-03       Impact factor: 3.517

9.  Chinese SLE Treatment and Research group (CSTAR) registry VII: prevalence and clinical significance of serositis in Chinese patients with systemic lupus erythematosus.

Authors:  J Zhao; W Bai; P Zhu; X Zhang; S Liu; L Wu; L Ma; L Bi; X Zuo; L Sun; C Huang; X Tian; M Li; Y Zhao; X Zeng
Journal:  Lupus       Date:  2016-01-12       Impact factor: 2.911

10.  Concurrent occurrence of chylothorax, chylous ascites, and protein-losing enteropathy in systemic lupus erythematosus.

Authors:  Chang-Keun Lee; Ji Min Han; Kung No Lee; Eun Young Lee; Jung Hyun Shin; You-Sook Cho; Younsuck Koh; Bin Yoo; Hee-Boom Moon
Journal:  J Rheumatol       Date:  2002-06       Impact factor: 4.666

View more
  1 in total

1.  Clinical characteristics of systemic lupus erythematosus with chylothorax and/or chylous ascites: An analysis of 15 cases in China.

Authors:  Guo-Hua Zhang; Ling-Ling Zhang; Yu-Hua Wang; Wen-Bin Shen
Journal:  Medicine (Baltimore)       Date:  2020-12-18       Impact factor: 1.817

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.